Real-time insider trades Start Free
Profitelligence
Masimo Corporation
MASI

Masimo Corporation

Szyman Catherine M. Files Masimo (MASI) Form 4 - February 12, 2026

| Form 4 |Healthcare

Transactions

Insider Date Type Shares Price Value Own
Szyman Catherine M. 2026-02-12 Sell 4.6K $0.00 $0.00 Direct
Szyman Catherine M. 2026-02-12 Sell 11.1K $0.00 $0.00 Direct
Szyman Catherine M. 2026-02-12 Buy 11.1K $132.96 $1.5M Direct
Profitelligence Profitelligence Alerts

Track MASI insider activity

Get alerts when Masimo Corporation executives trade their shares.

Set Up Alerts →

Advertisement

About Masimo Corporation

Masimo Corporation is a global leader in noninvasive monitoring technologies, specifically focusing on developing innovative medical devices that improve patient outcomes and reduce the cost of care. The company's flagship product line includes advanced signal processing pulse oximetry devices, which are pivotal in accurately measuring oxygen levels, pulse rate, and other vital signals without the need for invasive procedures. Masimo's technology is widely adopted across various healthcare settings including hospitals, outpatient treatment centers, and alternative care sites, enhancing patient monitoring and aiding clinicians in detecting potential health issues more efficiently. Besides, Masimo’s products are recognized for their precision and reliability, demonstrating robustness even in challenging clinical environments where motion and low perfusion can affect monitoring accuracy. The corporation is committed to expanding its technological suite, covering a spectrum of health monitoring solutions that contribute to improved healthcare practices globally. Based in Irvine, California, Masimo's ongoing innovation continues to set benchmarks in the healthcare industry, influencing a wide range of sectors from emergency care to surgical and critical care monitoring.

Exchange: NASDAQ Industry: Medical Devices Company Website

Official SEC Documents

MASI
MASI Research
Insider trades, 8Ks, financials, technicals
Form 4 Insider Tracker
See what executives are buying and selling

Advertisement